Showing results (21-30 of 192) with videos related to
Sort By:
Pageof 20
Nature Communications|August 30, 2019
Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicineGwen Lomberk, Nelson Dusetti, Juan Iovanna, et al.Translational Oncology|July 22, 2025
Understanding the heterogeneity of pancreatic ductal adenocarcinomaJuan Iovanna, Nicolas Fraunhoffer, Raul Urrutia, et al.Cancers|October 2, 2020
The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical ReviewSakti Chakrabarti, Hao Xie, Raul Urrutia, et al.The EMBO Journal|May 15, 2002
Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressorVolker Ellenrieder, Jin-San Zhang, Joanna Kaczynski, et al.Current Opinion in Gastroenterology|August 8, 2006
Key role of Krüppel-like factor proteins in pancreatic cancer and other gastrointestinal neoplasiasNavtej S Buttar, Martin E Fernandez-Zapico, Raul UrrutiaCurrent Opinion in Gastroenterology|January 6, 2009
The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer researchGwen Lomberk, Angela J Mathison, Adrienne Grzenda, et al.Current Opinion in Gastroenterology|October 13, 2006
Pancreatic cancer research: challenges, opportunities, and recent developmentsMartin E Fernandez-Zapico, Joanna A Kaczynski, Raul UrrutiaBiochimica Et Biophysica Acta|June 10, 2009
Sin3: master scaffold and transcriptional corepressorAdrienne Grzenda, Gwen Lomberk, Jin-San Zhang, et al.Endocrine Connections|September 8, 2025
Genomic features of the methylosome protein MEP50 and its implications in hormone signaling and cancerGareth Pollin, Young-In Chi, Raul Urrutia, et al.Bioinformatics (Oxford, England)|November 23, 2020
Structural bioinformatics enhances mechanistic interpretation of genomic variation, demonstrated through the analyses of 935 distinct RAS family mutationsSwarnendu Tripathi, Nikita R Dsouza, Raul Urrutia, et al.Pageof 20